Razmjoo S, Hosseini SM, Bagheri A, Feli M, Karimi F. Real-World Clinical Outcomes of Low Dose versus Standard Dose Abiraterone in Patients with Metastatic Castration-Resistant Prostate Cancer: A Prospective Pragmatic Study. apjcb [Internet]. 5Oct.2024 [cited 23Nov.2024];9(4):447-54. Available from: http://waocp.com/journal/index.php/apjcb/article/view/1482